Valuation: Alembic Pharmaceuticals Limited

Market Cap 162B 1.7B 1.49B 1.37B 1.27B 2.42B 2.45B 16.4B 6.37B 79.51B 6.39B 6.25B 275B P/E 2026
19.3x
P/E 2027 * 21.8x
Enterprise Value 168B 1.77B 1.55B 1.42B 1.32B 2.51B 2.55B 17.05B 6.63B 82.68B 6.64B 6.49B 285B EV / Sales 2026
1.93x
EV / Sales 2027 * 2.09x
Free-Float
29.3%
Yield 2026
1.81%
Yield 2027 * 1.56%
1 day+0.66%
1 week+6.77%
Current month+0.12%
1 month+13.54%
3 months+25.53%
6 months-1.36%
Current year-2.65%
1 week 773.1
Extreme 773.1
846
1 month 717.4
Extreme 717.4
846
Current year 635.8
Extreme 635.8
847.95
1 year 635.8
Extreme 635.8
1,044.8
3 years 629.6
Extreme 629.6
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 2025-07-06
Chief Tech/Sci/R&D Officer - 2023-06-30
Chief Operating Officer - 2025-07-20
Director TitleAgeSince
Chairman 78 2012-06-07
Director/Board Member 50 2006-12-31
Director/Board Member 66 2003-01-17
Date Insider Type Main position Quantity % Market Cap.
25-03-27
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
25-03-23
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
25-03-20Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+0.66%+6.77%-16.67%+29.43% 1.69B
+1.86%+7.65%+55.77%+158.84% 1,082B
+3.57%+7.42%+69.09%+58.92% 633B
+3.99%+7.37%+36.87%+93.77% 461B
+3.86%+1.85%+31.30%+24.86% 339B
-0.56%+2.80%+39.13%+28.20% 301B
-0.08%+1.52%+29.96%+42.13% 292B
-1.54%+3.56%-25.96%-40.53% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+4.21%+6.00%+17.72%+70.33% 163B
Average +1.95%+5.03%+26.33%+53.45% 370.14B
Weighted average by Cap. +2.24%+5.54%+41.76%+80.50%

Financials

2026 2027 *
Net sales 74.29B 780M 682M 626M 585M 1.11B 1.12B 7.53B 2.93B 36.49B 2.93B 2.87B 126B 82.16B 863M 754M 693M 647M 1.23B 1.24B 8.32B 3.23B 40.35B 3.24B 3.17B 139B
Net income 6.66B 69.99M 61.19M 56.19M 52.43M 99.44M 101M 675M 262M 3.27B 263M 257M 11.3B 7.47B 78.51M 68.64M 63.03M 58.82M 112M 113M 757M 294M 3.67B 295M 288M 12.67B
Net Debt 6.44B 67.68M 59.17M 54.33M 50.7M 96.16M 97.53M 653M 254M 3.16B 254M 249M 10.92B 9.54B 100M 87.65M 80.48M 75.11M 142M 144M 967M 376M 4.69B 376M 368M 16.18B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
16,571
Date Price Change Volume
26-07-03 ₹823.70 +0.66% 143,213
26-07-02 ₹818.30 -1.30% 116,150
26-07-01 ₹829.05 +0.77% 247,683
26-06-30 ₹822.75 +4.59% 919,045
26-06-29 ₹786.65 +1.96% 139,448
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
823.70INR
Average target price
907.70INR
Spread / Average Target
+10.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock